Forian Inc
FORA
查看詳細走勢圖
2.040USD
-0.120-5.56%
收盤 12/19, 16:00（美東）報價延遲15分鐘
63.23M總市值
虧損本益比TTM
盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
-5.56%
5天
-4.23%
1月
-6.42%
6月
-5.12%
今年開始到現在
-0.97%
1年
-3.77%
查看詳細走勢圖
TradingKey Forian Inc股票評分
單位: USD 更新時間: 2025-12-19操作建議
Forian Inc當前公司基本面數據相對非常健康，增長潛力很大。當前估值合理，在軟體與IT服務行業排名170/482位。機構持股佔比非常高，近一個月多位分析師給出公司評級為持有。最高目標價2.10。中期看，股價處於平穩狀態。近一個月，市場表現較差，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Forian Inc評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
1
分析師
持有
評級
2.100
目標均價
-2.33%
漲幅空間
數據免責聲明：分析師評級與目標價由LSEG提供，僅供參考，不應當作投資建議
Forian Inc亮點
亮點風險
Forian Inc. is a healthtech company. The Company is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. The Company provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its data ingestion, transformation, delivery services and business intelligence platforms are managed entirely via cloud-based data centers located in the United States. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and proprietary data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company’s solutions include CHRONOS, Chartis, RWE and Kyber Data Science.
業績增長期
公司處於發展階段，最新年度總收入20.15M美元
業績轉虧
公司業績轉虧，最新年度虧損美元
估值低估
公司最新PE估值-74.59，處於3年歷史低位
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉，最新持倉58.80K股
活躍度增加
近期活躍度增加，過去20天平均換手率2.36
Forian Inc新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Forian Inc簡介
Forian Inc. is a healthtech company. The Company is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. The Company provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its data ingestion, transformation, delivery services and business intelligence platforms are managed entirely via cloud-based data centers located in the United States. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and proprietary data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company’s solutions include CHRONOS, Chartis, RWE and Kyber Data Science.
公司代碼FORA
公司Forian Inc
CEOWygod (Max)
網址https://forian.com/
常見問題
Forian Inc(FORA)的當前股價是多少？
Forian Inc(FORA)的當前股價是 2.040。
Forian Inc 的股票代碼是什麼？
Forian Inc的股票代碼是FORA。
Forian Inc股票的52週最高點是多少？
Forian Inc股票的52週最高點是4.030。
Forian Inc股票的52週最低點是多少？
Forian Inc股票的52週最低點是1.640。
Forian Inc的市值是多少？
Forian Inc的市值是63.23M。
Forian Inc的淨利潤是多少？
Forian Inc的淨利潤為-3.77M。
現在Forian Inc(FORA)的股票是買入、持有還是賣出？
根據分析師評級，Forian Inc(FORA)的總體評級為持有，目標價格為2.100。
Forian Inc(FORA)股票的每股收益（EPS TTM）是多少
Forian Inc(FORA)股票的每股收益（EPS TTM）是-0.027。
相關品種
+1.60%
+1.55%
+0.40%
-0.85%
+0.92%
+6.87%
+1.01%
+4.14%
+0.41%
+1.66%
+0.02%
+0.20%
+0.71%
+3.89%
+1.66%
+0.89%
-0.49%
+3.52%
+0.01%
+0.54%
